Preparation of linear acrylate monomer based on side chain and its retardation film

By preparing linear acrylate monomers with side chains, the balance between transparency, film formation and birefringence of optical films for flexible display devices was solved, resulting in a phase retardation film with high transparency and excellent insulation, suitable for display devices.

CN119591500BActive Publication Date: 2026-11-10SHANJIN OPTOELECTRONICS (NANJING) CO
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202510091334.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-01-21
Publication Date
2026-11-10
Estimated Expiration
2045-01-21

AI Technical Summary

Technical Problem

Existing technologies struggle to meet the balance requirements of optical films for flexible and bendable display devices in terms of transparency, film-forming properties, birefringence, and optical delay effects, especially in terms of high transmittance and thin film performance.

Method used

A phase retardation film was prepared in an organic solution by using linear acrylate monomers with side chains and initiating polymerization with ultraviolet light. The transmittance, solubility and refractive properties of the film were controlled by multi-substituted benzylene side chains. The film was then formed with a thickness of less than 10 micrometers by spin coating or blade coating techniques.

Benefits of technology

A phase retardation film with high transparency, good film formation and excellent insulation has been achieved. It has optical dispersion and phase inverse wavelength delay effect and is suitable for display devices.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119591500B_ABST
    Figure CN119591500B_ABST
Patent Text Reader

Abstract

The present application relates to the preparation of a retardation film of a linear acrylate monomer with a side chain, which is a monomer terminated by an acrylate containing a side chain group, the ester group or amide side chain group containing at least one of a naphthyl group, a benzofuranyl group, a benzothiophenyl group, a benzothiazolyl group, and a glycol ether group. The phase difference retardation film composition obtained by polymerizing an oligomeric phenyl ester derivative monomer containing a polysubstituted phenyl alkyne side chain group with different components; the polysubstituted phenyl alkyne side chain of the linear acrylate monomer with a side chain has rich substituent groups, which effectively controls the light transmittance, solubility, film-forming property, refractive property, and insulating property of the film.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of compound technology, specifically to the preparation of a linear acrylate monomer with side chains and its delayed film. Background Technology

[0002] In recent years, new display technologies, represented by OLED displays, have achieved flexible, large-angle-bending, foldable, and transparent displays. These new functionalities in flat panel displays require optical films with high transmittance, thinner profiles, and good flexibility. Based on these requirements, various strategies have been employed to design and synthesize key monomers for resins with positive birefringence. These key monomers are designed and improved through various substitutions of their side chains to enhance film-forming properties, transparency, and birefringence, and to establish the relationship between wavelength dispersion and optical retardation effects, thus meeting the application requirements of various optical films for polarization state modulation. Acrylic-terminated benzoic acid ester oligomers possess excellent properties such as transparency, good solubility, ease of film formation, good refractive properties, and good insulation, and are therefore often used to prepare various optical thin films. These polymer thin films achieve birefringence through the directional arrangement of molecules. Summary of the Invention

[0003] The present invention aims to provide a linear acrylate monomer with side chains, having the structure shown in Formula I:

[0004]

[0005] Formula I is a linear acrylate monomer with a -COXA2A3 side chain, which is a monomer capped with an acrylate containing a side chain group. The -COXA2A3 side chain is composed of an ester group or an amide group, wherein the ester group or amide group contains at least one of naphthyl, benzofuranyl, benzothiopheneyl, benzothiazolyl, and ethylene glycol ether group.

[0006] Wherein, A1 is the bonding part of a single carbon atom, and A1 is CH2 or C=O;

[0007] X is linked by O, N, or CH2; when X is O, A2 is aryl or alkyl, and A3 is absent; when X is N, A2 is aryl or alkyl, and A3 is alkyl; when X is CH2O, A2 is aryl or alkyl, and A3 is absent.

[0008] A2 is selected from aryl or substituted aryl groups, including naphthyl, 4-tert-butylnaphthyl, benzothiazole, benzoxazole, benzofuran, and their substituted aryl groups.

[0009] A3 is selected from substituted alkyl groups, including alkyl and alkoxy-substituted alkyl groups; alkyl groups include methyl, ethyl, propyl, butyl, fluorinated alkyl, aryl substituted alkyl, and alkoxy-substituted alkyl groups; alkoxy-substituted alkyl groups include methoxyethyl, ethoxyethyl, propoxyethyl, butoxyethyl, and methoxyethoxyethyl.

[0010] Preferably, the linear acrylate monomer with side chains includes, but is not limited to, the following molecules: molecules 1, 2, and 3 with ester groups as side chains, and molecules 4, 5, and 6 with amide groups as side chains.

[0011]

[0012]

[0013]

[0014] The second objective of this invention is to provide a method for preparing a delayed film based on a linear acrylate monomer with side chains. The method involves preparing a solution of the linear acrylate monomer with side chains at a solid content of 10% and an acrylate derivative in an organic solution, initiating polymerization of the acrylate monomer and the acrylate derivative under the radiation energy of ultraviolet light absorbed by a photoinitiator, filtering, spin coating or blade coating, followed by heating, baking and ultraviolet irradiation.

[0015] Preferably, the wavelength of the ultraviolet light irradiation is 250-450nm.

[0016] Preferably, the delayed film is prepared under heating conditions of 10-150 degrees Celsius.

[0017] Preferably, the organic solution is a mixture of dichloromethane, ethyl acetate, ethyl formate, methyl acetate, dichloroethane, cyclohexanone, and acetone.

[0018] Preferably, the delay film is suitable for display devices, and the thickness of the delay film is less than 10 micrometers.

[0019] The present invention also provides an application of the prepared phase retardation film, which is suitable for display devices, and the thickness of the retardation film is less than 10 micrometers;

[0020] Compared with the prior art, the beneficial effects of the present invention are:

[0021] (1) The multi-substituted benzoynyl side chains in linear acrylate monomers with side chains have abundant substituent groups, which can effectively regulate the light transmittance, solubility, film-forming properties, refractive properties and insulation properties of the film.

[0022] (2) Polymer thin films achieve optical dispersion and phase inverse wavelength delay by changing the optical isotropy in the thin film plane. Specifically, anisotropy is achieved by stretching or designing the ordered arrangement of polymer molecules.

[0023] The present invention will now be further described with reference to the accompanying drawings. Attached Figure Description

[0024] Figure 1 This is a schematic diagram of the wavelength dispersion.

[0025] Figure 2 This is a spin-coating and heating diagram of molecular formula 5 in a specific embodiment of the present invention.

[0026] Figure 3 This is a wavelength-refractive index difference diagram of a molecularly prepared thin film in a specific embodiment of the present invention.

[0027] Figure 4 This is a wavelength-dispersion characteristic diagram of a molecularly prepared thin film according to a specific embodiment of the present invention.

[0028] Figure 5 This is molecule 1 of the specific embodiment of the present invention. 1 H NMR spectrum.

[0029] Figure 6 This is molecule 2 of the specific embodiment of the present invention. 1 H NMR spectrum.

[0030] Figure 7 This is molecule 3 of the specific embodiment of the present invention. 1 H NMR spectrum.

[0031] Figure 8 This is molecule 4 of the specific embodiment of the present invention. 1 H NMR spectrum.

[0032] Figure 9 This is a synthesis route diagram of specific embodiment 1 of the present invention.

[0033] Figure 10 This is a synthesis route diagram of specific embodiment 2 of the present invention.

[0034] Figure 11 This is a synthesis route diagram of specific embodiment 3 of the present invention.

[0035] Figure 12 This is a synthesis route diagram of specific embodiment 4 of the present invention.

[0036] Figure 13 This is a synthesis route diagram of specific embodiment 5 of the present invention.

[0037] Figure 14 This is a synthesis route diagram of specific embodiment 6 of the present invention. Detailed Implementation

[0038] A linear acrylate monomer with side chains is a monomer with acrylate-terminated side-chain groups, forming the ester group or amide side chain group, containing at least one of naphthyl, benzofuranyl, benzothiophene, benzothiazolyl, and glycol ether groups. A phase-delay film composition is obtained by polymerizing oligophenyl ester derivative monomers containing polysubstituted benzoynyl side chains with different components.

[0039] As shown in Equation 1

[0040]

[0041] In this general formula, A1 is the bonding part of a single carbon atom, and A1 is CH2 or C=O;

[0042] Where X is an O, N, CH2 bond;

[0043] When X is O, A2 is aryl or alkyl, and A3 is absent;

[0044] Where X is N, A2 is an aryl or alkyl group, and A3 is an alkyl chain;

[0045] When X is CH2O, A2 is aryl or alkyl, and A3 is absent;

[0046] Wherein, A2 is selected from aryl or substituted aryl, naphthyl, 4-tert-butylnaphthyl, benzothiazole, benzoxazole, benzofuran aryl substituent;

[0047] Wherein, A3 is selected from substituted alkyl groups, and the substituents include alkyl and alkoxy groups; alkyl groups include methyl, ethyl, propyl, butyl, fluorinated alkyl groups, and alkoxy-substituted alkyl groups; alkoxy groups include methoxy, ethoxy, propoxy, butoxy, methoxyethoxy, fluorinated alkyl groups, and aryl substituted alkyl groups.

[0048] The linear acrylate monomers with side chains include, but are not limited to, the following molecules: molecules 1, 2, and 3 with ester groups as side chains, and molecules 4, 5, and 6 with amide groups as side chains.

[0049]

[0050]

[0051]

[0052] A method for preparing a delayed-release film of a linear acrylate monomer with side chains involves polymerization under conditions containing at least a UV initiator, followed by UV exposure after film formation. The exposure wavelength is 250-450 nm. During the preparation of the delayed-release film, the linear acrylate monomer with side chains and various acrylate derivatives are polymerized in an organic solution using a photosensitizer. The film is prepared under heating conditions of 10-150 degrees Celsius. The organic solution is a mixture of dichloromethane, ethyl acetate, ethyl formate, methyl acetate, dichloroethane, cyclohexanone, and acetone.

[0053] The polymerized film is a phase retardation film suitable for display devices, with a thickness of less than 10 micrometers; a quarter-wavelength phase retardation film with a thickness of less than 5 micrometers.

[0054] The multi-substituted benzoynyl side chains in linear acrylate monomers with side chains have abundant substituent groups, which can effectively regulate the light transmittance, solubility, film-forming properties, refractive properties, and insulation characteristics of the film.

[0055] In the embodiments, the structure of the acrylate-terminated groups

[0056] Example 1

[0057] The synthesis process of molecular formula 1 is as follows Figure 9 As shown. Acid intermediate 1 (70 g, 75.51 mmol, 1 eq), intermediate naphthol (13.06 g, 90.61 mmol, 37.32 mL, 1.2 eq), and 4-dimethylaminopyridine (DMAP, 922.44 mg, 7.55 mmol, 0.1 eq) in dichloromethane (DCM, 700 mL) were added to a flask at 0 °C. 1-acetyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI, 17.37 g, 90.61 mmol, 1.2 eq) was then added. The mixture was stirred at 20 °C for 4 hours. The mixture was then added to 3 L of water, stirred for 10 minutes, and the pH was adjusted to 6 with dilute hydrochloric acid. The aqueous phase was then extracted with dichloromethane (1 L × 3), the organic phase was separated, the combined organic phases were washed with brine (2 L), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography and concentrated under reduced pressure to give a white solid. The target product molecule 1 was obtained (white solid, 41.5 g, 49.84% yield). MS: [M + H₂O + H] + =1070.8 m / z. Combined with... Figure 5 , 1HNMR(CD3Cl,400MHz)δ7.96-7.81(m,3H),7.69(d,J=1.6Hz,1H),7.58(d,J=3.2Hz,1H),7.5 4-7.44(m,2H),7.40-7.33(m,1H),7.18-7.08(m,1H),7.03-6.79(m,9H),6.41(d,J=17.2Hz, 2H),6.20-6.05(m,2H),5.83(d,J=10.4Hz,2H),4.28-4.14(m,4H),4.01-3.76(m,8H),2.61 -2.34(m,2H),2.29-2.13(m,4H),2.13-2.02(m,4H),1.87-1.37(m,22H),1.34-1.15(m,4H).

[0058] Example 2

[0059] The synthesis process of molecular formula 2 is as follows Figure 10 As shown. Acid intermediate 1 (70 g, 75.51 mmol, 1 eq), intermediate methoxyethoxyethanol (10.89 g, 90.6 mmol, 10.67 mL, 1.3 eq), DMAP (0.922 g, 7.55 mmol, 0.1 eq), and DCM (500 mL) were added to a flask at 0 °C. Then, EDCI (12.92 g, 67.42 mmol, 1.25 eq) was added to the solution. The mixture was stirred at 20 °C for 24 hours. The mixture was then added to 6 L of water, stirred for 10 minutes, and the acidity was adjusted to pH 6 with dilute hydrochloric acid. The aqueous phase was then extracted with dichloromethane (1.5 L × 4), and the organic phase was extracted by separation. The combined organic phases were washed with saturated brine (2 L × 2), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, DCM:EA = 10:1–5:1) and concentrated under reduced pressure to give a white solid. The target product molecule 2 was obtained (white solid, 51.8 g, 48.44 mmol, 64.16% yield). MS: [M + H2O + H] + =1046.9. Combined with... Figure 6 , 1HNMR (CDCl3, 400MHz): δ = 7.35 (d, J = 3.2Hz, 1H), 7.03-6.95 (m, 5H), 6.92-6.85 (m, 5H), 6.46-6.36 (m, 2 H),6.19-6.07(m,2H),5.86-5.79(m,2H),4.48(t,J=5.2Hz,2H),4.18(t,J=6.4Hz,4H),3.94(t,J=6.4 Hz,4H),3.88-3.81(m,4H),3.78(d,J=6.0Hz,2H),3.72-3.65(m,2H),3.61-3.54(m,2H),2.63-2.48(m ,2H),2.29-2.16(m,4H),2.12-2.00(m,4H),1.88-1.60(m,14H),1.53-1.42(m,8H),1.28-1.11(m,4H).

[0060] Example 3

[0061] The synthesis process of molecular formula 3 is as follows Figure 11 As shown. Acid intermediate 1 (70 g, 75.51 mmol, 1 eq), intermediate 2-(2-hydroxyethoxy)ethyl acrylate (13.64 g, 83 mmol, 1.1 eq), DMAP (0.922 g, 7.55 mmol, 0.1 eq), and DCM (700 mL) were added to a flask at 0 °C. Then, EDCI (18.8 g, 98.16 mmol, 1.3 eq) was added to the solution. The mixture was stirred at 20 °C for 24 hours. The mixture was then added to 6 L of water, stirred for 10 minutes, and the pH was adjusted to 6 with dilute hydrochloric acid. The aqueous phase was then extracted with dichloromethane (1.5 L × 4), and the organic phase was extracted separately. The combined organic phases were washed with saturated brine (2 L × 2), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, DCM:EA = 30:1–5:1) and concentrated under reduced pressure to obtain a white solid of the target product molecule 3 (35 g, 29.36 mmol, 54.4% yield). MS: [M + H2O + H] + =1086.7. Combined with... Figure 7 , 1H NMR (CDCl3, 400MHz): δ7.34 (d, J = 3.2Hz, 1H), 7.06-6.93 (m, 5H), 6.93-6.81 (m, 5H), 6.51 -6.34(m,3H),6.23-6.08(m,3H),5.90-5.75(m,3H),4.57-4.44(m,2H),4.39-4.28(m,2H ),4.18(t,J=6.8Hz,4H),3.95(t,J=6.4Hz,4H),3.88-3.75(m,8H),2.52(s,2H),2.30-2. 17(m,4H),2.12-1.96(m,4H),1.90-1.56(m,14H),1.56-1.38(m,8H),1.30-1.12(m,4H).

[0062] Example 4

[0063] The synthesis process of molecular formula 4 is as follows Figure 12 As shown. Acid intermediate 1 (70 g, 75.51 mmol, 1 eq), intermediate N-methylbenzothiazol-2-amine (13.64 g, 83 mmol, 1.1 eq), DMAP (0.922 g, 7.55 mmol, 0.1 eq), and DCM (700 mL) were added to a flask at 0 °C. Then, EDCI (18.8 g, 98.16 mmol, 1.3 eq) was added to the solution. The mixture was stirred at 20 °C for 24 hours. The mixture was then added to 6 L of water, stirred for 10 minutes, and the pH was adjusted to 6 with dilute hydrochloric acid. The aqueous phase was then extracted with dichloromethane (1.5 L × 4), and the organic phase was extracted separately. The combined organic phases were washed with saturated brine (2 L × 2), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, DCM:EA = 10:1–5:1) and concentrated under reduced pressure to give a white solid. The target product molecule 4 was obtained as a white solid (49 g, 43.37 mmol, 57.44% yield). MS: [M+H] + =1073.8. Combined with... Figure 8 , 1H NMR (CDCl3, 400MHz): δ=7.96-7.84(m,2H),7.50-7.41(m,1H),7.37-7.31(m,1H),7.01 -6.81(m,11H),6.47-6.34(m,2H),6.24-6.07(m,2H),5.89-5.76(m,2H),4.21-4.13(m ,4H),4.01-3.90(m,4H),3.85-3.73(m,4H),3.67(s,3H),2.58-2.46(m,1H),2.34-2.1 6(m,3H),2.12-2.01(m,4H),1.89-1.59(m,16H),1.51-1.44(m,8H),1.27-1.00(m,4H).

[0064] Example 5

[0065] The synthesis process of molecular formula 5 is as follows Figure 13 As shown. Acid intermediate 1 (70 g, 75.51 mmol, 1 eq), intermediate 2-methoxyethoxyethyl-benzothiophene-2-amine (10.89 g, 90.6 mmol, 10.67 mL, 1.3 eq), DMAP (0.922 g, 7.55 mmol, 0.1 eq), and DCM (900 mL) were added to a flask at 0 °C. EDCI (18.8 g, 98.16 mmol, 1.3 eq) was then added to the solution. The mixture was stirred at 20 °C for 48 hours. The mixture was then added to 6 L of water, stirred for 10 minutes, and the pH was adjusted to 6 with dilute hydrochloric acid. The aqueous phase was then extracted with dichloromethane (1.5 L × 4), and the organic phase was extracted separately. The combined organic phases were washed with saturated brine (2 L × 2), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, DCM:EA = 10:1–3:1) and concentrated under reduced pressure to give a white solid. The target product molecule 5 was obtained as a white solid (46.2 g, 39.8 mmol, 52.7% yield). MS: [M+H] + =1161.8.

[0066] Example 6

[0067] The synthesis process of molecular formula 6 is as follows Figure 14As shown. Acid intermediate 1 (70 g, 75.51 mmol, 1 eq), intermediate 2 (21.64 g, 83 mmol, 1.1 eq), DMAP (0.922 g, 7.55 mmol, 0.1 eq), and DCM (900 mL) were added to a flask at 0 °C. Then, EDCI (18.8 g, 98.16 mmol, 1.3 eq) was added to the solution. The mixture was stirred at 20 °C for 24 hours. The mixture was then added to 6 L of water, stirred for 10 minutes, and the pH was adjusted to 6 with dilute hydrochloric acid. The aqueous phase was then extracted with dichloromethane (1.5 L × 4), and the organic phase was extracted separately. The combined organic phases were washed with saturated brine (2 L × 2), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography (SiO2, DCM:EA = 1:0–3:1) and concentrated under reduced pressure to give a white solid. A white solid, molecule 6, was obtained as the target product. (53.3 g, 44.37 mmol, 58.77% yield). MS: [M+H] + =1202.5.

[0068] Example 7

[0069] In this embodiment, the molecules described in the six embodiments above were prepared into a solution in ethyl acetate with a solid content of 10%, and 1 wt% of a photoinitiator was added. After conventional filtration, the solution was spin-coated or blade-coated onto an alignment film and then baked at 100°C to remove the solvent. Irradiation with 365 nm ultraviolet light resulted in a film exhibiting distinct bright and dark states. The film was then peeled off and used to fabricate a phase retardation film. The thickness of the prepared film was within 0.9–1.1 μm. Axostep testing of the optical film's phase retardation showed that the phase retardation of the optical film exhibited demonstrative characteristics within the range of -50.00° to +50.00°. The thickness, R0, and Δn values ​​of the obtained film from 450 nm to 650 nm are shown in the table below:

[0070]

[0071] Combination Figure 1-4 The test results showed that after photocuring, all films of the molecularly oriented coating exhibited distinct light and dark phases; combined with Figure 2 The prepared thin film exhibits anisotropy. Figure 3The delay per unit thickness along the x and y axes of molecules 1, 4, 5, and 6 increases with increasing wavelength, indicating that the films prepared by molecules 1, 4, 5, and 6 exhibit reverse wavelength dispersion. Molecules 2, 3, and the exemplary example exhibit positive wavelength dispersion. By adjusting the film thickness, films with a thickness of approximately 2.5 micrometers were prepared. The Ro@550nm values ​​of the films corresponding to molecules 1, 4, 5, 2, 3, and 6 were 137.5 nm, 141.5 nm, 141.5 nm, 135.2 nm, 132.8 nm, and 146.5 nm, respectively, exhibiting a 1 / 4 wavelength phase difference delay effect, which can be used to fabricate 1 / 4 wavelength circularly polarized optical delay films.

Claims

1. A linear acrylate monomer with side chains, characterized in that, It has the structure shown in Equation I: Formula I Formula I is a linear acrylate monomer with a -COXA2A3 side chain, which is a monomer capped with an acrylate containing a side chain group. The -COXA2A3 side chain is composed of an ester group or an amide group, wherein the ester group or amide group contains at least one of naphthyl, benzofuranyl, benzothiopheneyl, benzothiazolyl, and ethylene glycol ether group. Wherein, A1 is the bonding part of a single carbon atom, and A1 is CH2 or C=O; X is linked by O, N, or CH2; when X is O, A2 is aryl or alkyl, and A3 is absent; when X is N, A2 is aryl or alkyl, and A3 is alkyl; when X is CH2O, A2 is aryl or alkyl, and A3 is absent. A2 is selected from aryl or substituted aryl groups, including naphthyl, 4-tert-butylnaphthyl, benzothiazole, benzoxazole, benzofuran, and their substituted aryl groups. A3 is selected from substituted alkyl groups, including alkyl and alkoxy-substituted alkyl groups; alkyl groups include methyl, ethyl, propyl, butyl, fluorinated alkyl, aryl substituted alkyl, and alkoxy-substituted alkyl groups; alkoxy-substituted alkyl groups include methoxyethyl, ethoxyethyl, propoxyethyl, butoxyethyl, and methoxyethoxyethyl. The linear acrylate monomer with side chains has amide groups at molecule 4, 5, and 6. Molecular 4 Molecular 5 Molecular 6.

2. A method for preparing a delayed-release film based on the linear acrylate monomer with side chains as described in claim 1, characterized in that, A solution of linear acrylate monomers with side chains and acrylate derivatives with a solid content of 10% is prepared in an organic solvent. The polymerization of acrylate monomers and acrylate derivatives is initiated by a photoinitiator absorbing the radiation energy of ultraviolet light. After filtration, spin coating or blade coating, the mixture is heated, baked and irradiated with ultraviolet light.

3. The method for preparing a delayed film according to claim 2, characterized in that, The corresponding wavelength for ultraviolet light irradiation is 250-450 nm.

4. The method for preparing a delayed film according to claim 2, characterized in that, The delayed film is prepared by heating at 10-150 degrees Celsius.

5. The method for preparing a delayed film according to claim 2, characterized in that, The organic solution is a mixture of dichloromethane, ethyl acetate, ethyl formate, methyl acetate, dichloroethane, cyclohexanone, and acetone.

6. An application based on the linear acrylate monomer with side chains as described in claim 1, characterized in that, A retardation film prepared from linear acrylate monomers with side chains is used in display devices. The thickness of the retardation film is less than 10 micrometers.

Citation Information

Patent Citations

  • Polymerizable compound, polymer, polymerizable composition, film, and half mirror for projection image display

    CN106164108A

  • Polymerizable compound, polymerizable liquid crystal composition, polymer, retardation film and method for producing the same, transfer laminate, optical member and method for producing the same, and display device

    JP2021162658A

  • Optical film, polarizing plate, and image display device

    US20180079958A1